Last 12 months
Inside the activity.
0 purchase rows · 10 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 7 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 27, 2024 Filed Aug 29, 2024 21:02 UTC |
Sherbet EricSee Remarks
|
SaleCommon Stock | 1,300 | $246.33 | $320,229.00 |
DisclosureSEC source: 0001478242-24-000107 · wk-form4_1724965363.xml · nonDerivative · entry 1 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,536 Read SEC document |
| July 28, 2024 Filed Jul 30, 2024 21:00 UTC |
Cherofsky KeriannSee Remarks
|
Tax withholdingCommon Stock | 35 | $239.67 | $8,388.45 |
DisclosureSEC source: 0001478242-24-000104 · wk-form4_1722373213.xml · nonDerivative · entry 1 Cherofsky Keriann · CIK 0001940591 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 753 Read SEC document |
| July 28, 2024 Filed Jul 30, 2024 21:01 UTC |
Patel BhavikSee Remarks
|
Tax withholdingCommon Stock | 83 | $239.67 | $19,892.61 |
DisclosureSEC source: 0001478242-24-000105 · wk-form4_1722373283.xml · nonDerivative · entry 1 Patel Bhavik · CIK 0002023629 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 545 Read SEC document |
| July 18, 2024 Filed Jul 22, 2024 21:00 UTC |
DANHAKL JOHN GDirector
|
GrantDeferred Shares · Derivative | 134 | $224.85 | $30,129.90 |
DisclosureSEC source: 0001478242-24-000098 · wk-form4_1721682025.xml · derivative · entry 1 DANHAKL JOHN G · CIK 0001162644 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,988 Underlying: Common Stock · 134 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| July 18, 2024 Filed Jul 22, 2024 21:02 UTC |
Wims Morris LeslieDirector
|
GrantDeferred Shares · Derivative | 123 | $224.85 | $27,656.55 |
DisclosureSEC source: 0001478242-24-000101 · wk-form4_1721682134.xml · derivative · entry 1 Wims Morris Leslie · CIK 0001908079 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,423 Underlying: Common Stock · 123 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| July 18, 2024 Filed Jul 22, 2024 21:01 UTC |
GOGGINS COLLEEN ADirector
|
GrantDeferred Shares · Derivative | 156 | $224.85 | $35,076.60 |
DisclosureSEC source: 0001478242-24-000100 · wk-form4_1721682102.xml · derivative · entry 1 GOGGINS COLLEEN A · CIK 0001189008 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,790 Underlying: Common Stock · 156 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| July 18, 2024 Filed Jul 22, 2024 21:01 UTC |
Fasano JimDirector
|
GrantDeferred Shares · Derivative | 155 | $224.85 | $34,851.75 |
DisclosureSEC source: 0001478242-24-000099 · wk-form4_1721682066.xml · derivative · entry 1 Fasano Jim · CIK 0001633043 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,518 Underlying: Common Stock · 155 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| May 07, 2024 Filed May 9, 2024 21:07 UTC |
DANHAKL JOHN GDirector
|
GrantDeferred Shares · Derivative | 131 | $229.14 | $30,017.34 |
DisclosureSEC source: 0001478242-24-000081 · wk-form4_1715288845.xml · derivative · entry 3 DANHAKL JOHN G · CIK 0001162644 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,854 Underlying: Common Stock · 131 shares Expires not disclosed F3 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F3 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F3 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| May 07, 2024 Filed May 9, 2024 21:07 UTC |
DANHAKL JOHN GDirector
|
GrantCommon Stock | 1,047 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-24-000081 · wk-form4_1715288845.xml · nonDerivative · entry 1 DANHAKL JOHN G · CIK 0001162644 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 27,449 F1 · shares: Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant. F2 · ownership.nature: Shares held in the Danhakl Revocable Family Trust. Read SEC document |
| May 07, 2024 Filed May 9, 2024 21:06 UTC |
Burt CarolDirector
|
GrantDeferred Shares · Derivative | 1,047 | $229.14 | $239,909.58 |
DisclosureSEC source: 0001478242-24-000080 · wk-form4_1715288798.xml · derivative · entry 1 Burt Carol · CIK 0001493926 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,047 Underlying: Common Stock · 1,047 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| May 07, 2024 Filed May 9, 2024 21:09 UTC |
GOGGINS COLLEEN ADirector
|
GrantDeferred Shares · Derivative | 153 | $229.14 | $35,058.42 |
DisclosureSEC source: 0001478242-24-000084 · wk-form4_1715288965.xml · derivative · entry 3 GOGGINS COLLEEN A · CIK 0001189008 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,634 Underlying: Common Stock · 153 shares Expires not disclosed F2 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F2 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F2 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| May 07, 2024 Filed May 9, 2024 21:09 UTC |
GOGGINS COLLEEN ADirector
|
GrantCommon Stock | 1,047 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-24-000084 · wk-form4_1715288965.xml · nonDerivative · entry 1 GOGGINS COLLEEN A · CIK 0001189008 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,290 F1 · shares: Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant. Read SEC document |
| May 07, 2024 Filed May 9, 2024 21:09 UTC |
Fasano JimDirector
|
GrantDeferred Shares · Derivative | 1,200 | $229.14 | $274,968.00 |
DisclosureSEC source: 0001478242-24-000083 · wk-form4_1715288930.xml · derivative · entry 2 Fasano Jim · CIK 0001633043 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,363 Underlying: Common Stock · 1,200 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| May 07, 2024 Filed May 9, 2024 21:08 UTC |
Wims Morris LeslieDirector
|
GrantDeferred Shares · Derivative | 1,167 | $229.14 | $267,406.38 |
DisclosureSEC source: 0001478242-24-000082 · wk-form4_1715288887.xml · derivative · entry 2 Wims Morris Leslie · CIK 0001908079 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,300 Underlying: Common Stock · 1,167 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| May 07, 2024 Filed May 9, 2024 21:06 UTC |
LEONARD JOHN MDirector
|
GrantCommon Stock | 1,047 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-24-000079 · wk-form4_1715288757.xml · nonDerivative · entry 1 LEONARD JOHN M · CIK 0001563584 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,783 F1 · shares: Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant. Read SEC document |
| May 07, 2024 Filed May 9, 2024 21:05 UTC |
Stamps Sheila ADirector
|
GrantDeferred Shares · Derivative | 1,047 | $229.14 | $239,909.58 |
DisclosureSEC source: 0001478242-24-000078 · wk-form4_1715288714.xml · derivative · entry 1 Stamps Sheila A · CIK 0001600782 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,047 Underlying: Common Stock · 1,047 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| May 07, 2024 Filed May 9, 2024 21:04 UTC |
CONNAUGHTON JOHNDirector
|
GrantCommon Stock | 1,047 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-24-000077 · wk-form4_1715288664.xml · nonDerivative · entry 1 CONNAUGHTON JOHN · CIK 0001213395 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,047 F1 · shares: Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant. Read SEC document |
| March 01, 2024 Filed Mar 4, 2024 22:28 UTC |
BOUSBIB ARIDirector · See Remarks
|
Exercise / conversionStock Appreciation Right · Derivative | 42,847 | $65.16 Strike: $65.16 | $2,791,910.52 |
DisclosureSEC source: 0001478242-24-000058 · wk-form4_1709591310.xml · derivative · entry 6 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 42,847 shares Expires 2025-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2024 Filed Mar 4, 2024 22:28 UTC |
BOUSBIB ARIDirector · See Remarks
|
Disposition to issuerCommon Stock | 11,169 | $249.97 | $2,791,914.93 |
DisclosureSEC source: 0001478242-24-000058 · wk-form4_1709591310.xml · nonDerivative · entry 4 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 785,583 Read SEC document |
| March 01, 2024 Filed Mar 4, 2024 22:28 UTC |
BOUSBIB ARIDirector · See Remarks
|
SaleCommon Stock | 15,417 | $251.03 | $3,870,129.51 |
DisclosureSEC source: 0001478242-24-000058 · wk-form4_1709591310.xml · nonDerivative · entry 3 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 796,752 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $250.50 to $251.41, inclusive. Read SEC document |
| March 01, 2024 Filed Mar 4, 2024 22:28 UTC |
BOUSBIB ARIDirector · See Remarks
|
SaleCommon Stock | 16,261 | $250.05 | $4,066,063.05 |
DisclosureSEC source: 0001478242-24-000058 · wk-form4_1709591310.xml · nonDerivative · entry 2 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 812,169 F1 · price: The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $249.42 to $250.39 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| March 01, 2024 Filed Mar 4, 2024 22:28 UTC |
BOUSBIB ARIDirector · See Remarks
|
Exercise / conversionCommon Stock | 42,847 | $65.16 | $2,791,910.52 |
DisclosureSEC source: 0001478242-24-000058 · wk-form4_1709591310.xml · nonDerivative · entry 1 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 828,430 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 29, 2024 Filed Mar 4, 2024 22:27 UTC |
STAUB W RICHARDSee Remarks
|
SaleCommon Stock | 2,068 | $249.08 | $515,097.44 |
DisclosureSEC source: 0001478242-24-000057 · wk-form4_1709591202.xml · nonDerivative · entry 3 STAUB W RICHARD · CIK 0001181162 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,945 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $248.84 to $249.47, inclusive. Read SEC document |
| February 29, 2024 Filed Mar 4, 2024 22:27 UTC |
STAUB W RICHARDSee Remarks
|
SaleCommon Stock | 3,062 | $248.33 | $760,386.46 |
DisclosureSEC source: 0001478242-24-000057 · wk-form4_1709591202.xml · nonDerivative · entry 2 STAUB W RICHARD · CIK 0001181162 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,013 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $247.84 to $248.82, inclusive. Read SEC document |
| February 29, 2024 Filed Mar 4, 2024 22:27 UTC |
STAUB W RICHARDSee Remarks
|
SaleCommon Stock | 8,970 | $247.33 | $2,218,550.10 |
DisclosureSEC source: 0001478242-24-000057 · wk-form4_1709591202.xml · nonDerivative · entry 1 STAUB W RICHARD · CIK 0001181162 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,075 F1 · price: The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $246.84 to $247.83 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 22:07 UTC |
Knightly Kevin CSee Remarks
|
Exercise / conversionStock Appreciation Right · Derivative | 7,131 | $95.23 Strike: $95.23 | $679,085.13 |
DisclosureSEC source: 0001478242-24-000054 · wk-form4_1709330833.xml · derivative · entry 7 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,263 Underlying: Common Stock · 7,131 shares Expires 2028-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 22:07 UTC |
Knightly Kevin CSee Remarks
|
Exercise / conversionStock Appreciation Right · Derivative | 6,075 | $78.21 Strike: $78.21 | $475,125.75 |
DisclosureSEC source: 0001478242-24-000054 · wk-form4_1709330833.xml · derivative · entry 6 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,075 shares Expires 2027-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 22:07 UTC |
Knightly Kevin CSee Remarks
|
Disposition to issuerCommon Stock | 4,599 | $251.02 | $1,154,440.98 |
DisclosureSEC source: 0001478242-24-000054 · wk-form4_1709330833.xml · nonDerivative · entry 5 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 652 Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 22:07 UTC |
Knightly Kevin CSee Remarks
|
SaleCommon Stock | 2,182 | $250.83 | $547,311.06 |
DisclosureSEC source: 0001478242-24-000054 · wk-form4_1709330833.xml · nonDerivative · entry 4 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,251 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $250.59 to $251.07, inclusive. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 22:07 UTC |
Knightly Kevin CSee Remarks
|
SaleCommon Stock | 6,425 | $249.94 | $1,605,864.50 |
DisclosureSEC source: 0001478242-24-000054 · wk-form4_1709330833.xml · nonDerivative · entry 3 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,433 F1 · price: The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $249.48 to $250.47 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 22:07 UTC |
Knightly Kevin CSee Remarks
|
Exercise / conversionCommon Stock | 7,131 | $95.23 | $679,085.13 |
DisclosureSEC source: 0001478242-24-000054 · wk-form4_1709330833.xml · nonDerivative · entry 2 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,858 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 22:07 UTC |
Knightly Kevin CSee Remarks
|
Exercise / conversionCommon Stock | 6,075 | $78.21 | $475,125.75 |
DisclosureSEC source: 0001478242-24-000054 · wk-form4_1709330833.xml · nonDerivative · entry 1 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,727 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 22:08 UTC |
Sherbet EricSee Remarks
|
SaleCommon Stock | 1,000 | $241.50 | $241,500.00 |
DisclosureSEC source: 0001478242-24-000048 · wk-form4_1708553297.xml · nonDerivative · entry 1 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,836 Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 22:07 UTC |
Knightly Kevin CSee Remarks
|
Exercise / conversionStock Appreciation Right · Derivative | 12,149 | $78.21 Strike: $78.21 | $950,173.29 |
DisclosureSEC source: 0001478242-24-000047 · wk-form4_1708553237.xml · derivative · entry 7 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,075 Underlying: Common Stock · 12,149 shares Expires 2027-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 22:07 UTC |
Knightly Kevin CSee Remarks
|
SaleCommon Stock | 4,021 | $241.38 | $970,588.98 |
DisclosureSEC source: 0001478242-24-000047 · wk-form4_1708553237.xml · nonDerivative · entry 6 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 652 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $241.01 to $241.61, inclusive. Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 22:07 UTC |
Knightly Kevin CSee Remarks
|
SaleCommon Stock | 1,239 | $240.73 | $298,264.47 |
DisclosureSEC source: 0001478242-24-000047 · wk-form4_1708553237.xml · nonDerivative · entry 5 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,673 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $239.99 to $240.95, inclusive. Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 22:07 UTC |
Knightly Kevin CSee Remarks
|
Disposition to issuerCommon Stock | 3,941 | $241.14 | $950,332.74 |
DisclosureSEC source: 0001478242-24-000047 · wk-form4_1708553237.xml · nonDerivative · entry 4 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,912 Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 22:07 UTC |
Knightly Kevin CSee Remarks
|
SaleCommon Stock | 4,867 | $241.23 | $1,174,066.41 |
DisclosureSEC source: 0001478242-24-000047 · wk-form4_1708553237.xml · nonDerivative · entry 3 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,853 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $241.01 to $241.54, inclusive. Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 22:07 UTC |
Knightly Kevin CSee Remarks
|
SaleCommon Stock | 3,341 | $240.72 | $804,245.52 |
DisclosureSEC source: 0001478242-24-000047 · wk-form4_1708553237.xml · nonDerivative · entry 2 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,720 F1 · price: The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $240.00 to $240.95 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2),(3) and (4) to this Form 4. Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 22:07 UTC |
Knightly Kevin CSee Remarks
|
Exercise / conversionCommon Stock | 12,149 | $78.21 | $950,173.29 |
DisclosureSEC source: 0001478242-24-000047 · wk-form4_1708553237.xml · nonDerivative · entry 1 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,061 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2024 Filed Feb 13, 2024 22:09 UTC |
Cherofsky KeriannSee Remarks
|
Tax withholdingCommon Stock | 15 | $218.20 | $3,273.00 |
DisclosureSEC source: 0001478242-24-000028 · wk-form4_1707862130.xml · nonDerivative · entry 2 Cherofsky Keriann · CIK 0001940591 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 788 Read SEC document |
| February 10, 2024 Filed Feb 13, 2024 22:12 UTC |
STAUB W RICHARDSee Remarks
|
Tax withholdingCommon Stock | 215 | $218.20 | $46,913.00 |
DisclosureSEC source: 0001478242-24-000031 · wk-form4_1707862307.xml · nonDerivative · entry 2 STAUB W RICHARD · CIK 0001181162 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,045 Read SEC document |
| February 10, 2024 Filed Feb 13, 2024 22:11 UTC |
Sherbet EricSee Remarks
|
Tax withholdingCommon Stock | 289 | $218.20 | $63,059.80 |
DisclosureSEC source: 0001478242-24-000030 · wk-form4_1707862236.xml · nonDerivative · entry 2 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,836 Read SEC document |
| February 10, 2024 Filed Feb 13, 2024 22:10 UTC |
Knightly Kevin CSee Remarks
|
Tax withholdingCommon Stock | 303 | $218.20 | $66,114.60 |
DisclosureSEC source: 0001478242-24-000029 · wk-form4_1707862190.xml · nonDerivative · entry 2 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,912 Read SEC document |
| February 10, 2024 Filed Feb 13, 2024 22:07 UTC |
BOUSBIB ARIDirector · See Remarks
|
Tax withholdingCommon Stock | 3,335 | $218.20 | $727,697.00 |
DisclosureSEC source: 0001478242-24-000026 · wk-form4_1707862037.xml · nonDerivative · entry 2 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 785,583 Read SEC document |
| February 10, 2024 Filed Feb 13, 2024 22:08 UTC |
Bruehlman Ronald ESee Remarks
|
Tax withholdingCommon Stock | 907 | $218.20 | $197,907.40 |
DisclosureSEC source: 0001478242-24-000027 · wk-form4_1707862086.xml · nonDerivative · entry 2 Bruehlman Ronald E · CIK 0001604076 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,391 Read SEC document |
| February 09, 2024 Filed Feb 13, 2024 22:09 UTC |
Cherofsky KeriannSee Remarks
|
Tax withholdingCommon Stock | 61 | $218.20 | $13,310.20 |
DisclosureSEC source: 0001478242-24-000028 · wk-form4_1707862130.xml · nonDerivative · entry 1 Cherofsky Keriann · CIK 0001940591 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 803 Read SEC document |
| February 09, 2024 Filed Feb 13, 2024 22:12 UTC |
STAUB W RICHARDSee Remarks
|
Tax withholdingCommon Stock | 353 | $218.20 | $77,024.60 |
DisclosureSEC source: 0001478242-24-000031 · wk-form4_1707862307.xml · nonDerivative · entry 1 STAUB W RICHARD · CIK 0001181162 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,260 Read SEC document |
| February 09, 2024 Filed Feb 13, 2024 22:11 UTC |
Sherbet EricSee Remarks
|
Tax withholdingCommon Stock | 281 | $218.20 | $61,314.20 |
DisclosureSEC source: 0001478242-24-000030 · wk-form4_1707862236.xml · nonDerivative · entry 1 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,125 Read SEC document |
| February 09, 2024 Filed Feb 13, 2024 22:10 UTC |
Knightly Kevin CSee Remarks
|
Tax withholdingCommon Stock | 311 | $218.20 | $67,860.20 |
DisclosureSEC source: 0001478242-24-000029 · wk-form4_1707862190.xml · nonDerivative · entry 1 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,215 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.